EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Phillygenin, a Plant-Derived Lignan, Attenuates Renal Inflammation, Fibrosis, and Pyroptosis in a Unilateral Ureteral Obstruction Model

Yu-Syuan Chen, Shun-Fa Yang iD, Huey-Liang Kuo, Haw-Ling Chuang, Chang-Mu Chen, Ssu-Chia Lin, Pei-Yu Weng, Chun-Fa Huang iD, Siao-Syun Guan iD, Shing-Hwa Liu iD, Cheng-Tien Wu iD

Nutrients · 30.04.2026 · 18 (9) · 1421

DOI: 10.3390/nu18091421 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 30.04.2026. Verfasst von Yu-Syuan Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, China Medical University, Taichung 40402, Taiwan. Hauptthemen laut MEDLINE: Ureteral Obstruction, Lignans, Pyroptosis, Kidney. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Medical University, Taiwan, the Buddhist Tzuchi Medical Foundation of the Taichung Tzu Chi Hospital, Taiwan, the National Science and Technology Council, Taipei, Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Phillygenin (PHI), a natural lignan derived from Forsythia suspensa, has garnered attention for its potential to alleviate chronic diseases, including chronic colitis, pulmonary fibrosis, and diabetes. Chronic kidney disease (CKD) poses a global health challenge, characterized by high morbidity and mortality rates and associated with a spectrum of secondary complications. In this study, we aim to investigate the therapeutic effectiveness of PHI on CKD and also identify molecular signals by using a unilateral ureteral obstruction (UUO) mouse model and in vitro experiments.

Methods

C57BL/6 mice were administered PHI at 50 mg/kg/day to assess its therapeutic effectiveness. In vitro, lipopolysaccharide (LPS) and adenosine triphosphate (ATP) were used to induce pyroptosis, also known as pyroptosis, in renal proximal tubular cells (NRK52E).

Results

After PHI treatment for 14 consecutive days, the collagen deposition and extracellular matrix (ECM) accumulation, the expression of oxidative stress response proteins (catalase, superoxide dismutase 2, NADPH oxidase 4, and thioredoxin reductase 1), pro-inflammatory markers (TNF-α and Cyclooxygenase-2(COX-2), and infiltration of neutrophils and macrophages were significantly ameliorated in the UUO mice. Interestingly, the pyroptosis-related proteins (NLRP3/Caspase-1/GSDMD/IL-1β) and cell apoptotic death were also conspicuously relieved after treatment with PHI. Furthermore, PHI administration significantly attenuated the ATP/LPS-induced NF-κB/NLRP3/Caspase-1/GSDMD pyroptosis signal pathway in NRK52E cells.

Conclusions

These results demonstrate, for the first time, that PHI treatment ameliorates inflammation and the related pyroptosis via inhibitory regulation of the NF-κB/NLRP3/Caspase-1/GSDMD axis, leading to attenuated renal fibrosis and progressive CKD in UUO mice and in vitro. Our findings suggest that PHI could be a nutraceutical candidate for attenuating CKD progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ureteral ObstructionLignansPyroptosisKidneyRenal Insufficiency, ChronicAnimalsMice, Inbred C57BLFibrosisMaleDisease Models, AnimalMiceOxidative StressCell LineSignal Transduction

Stichwörter der Autor:innen

chronic kidney diseasefibrosisinflammationphillygeninpyroptosisunilateral ureteral obstruction

Substanzen

Lignans

Autor:innen und Institutionen

  • Department of Nutrition, China Medical University, Taichung 40402, Taiwan.
  • Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
  • Department of Medical Research, Chung Shan Medical University Hospital, Taichung 40201, Taiwan.
  • Division of Nephrology, Department of Internal Medicine, China Medical University Hospital, Taichung 40402, Taiwan.
  • School of Medicine, College of Medicine, China Medical University, Taichung 40402, Taiwan.
  • Clinical Nutrition, China Medical University Hospital, Taichung 40402, Taiwan.

ORCID-Profile: Shun-Fa Yang, Chun-Fa Huang, Siao-Syun Guan, Shing-Hwa Liu, Cheng-Tien Wu

Förderung

  • China Medical University, Taiwan
  • the Buddhist Tzuchi Medical Foundation of the Taichung Tzu Chi Hospital, Taiwan
  • the National Science and Technology Council, Taipei, Taiwan

Zitieren

APA

Chen, Y. S., Yang, S. F., Kuo, H. L., Chuang, H. L., Chen, C. M., Lin, S. C., Weng, P. Y., Huang, C. F., Guan, S. S., Liu, S. H., & Wu, C. T. (2026). Phillygenin, a Plant-Derived Lignan, Attenuates Renal Inflammation, Fibrosis, and Pyroptosis in a Unilateral Ureteral Obstruction Model. Nutrients, 18(9), 1421. https://doi.org/10.3390/nu18091421

Vancouver

Chen YS, Yang SF, Kuo HL, Chuang HL, Chen CM, Lin SC, et al. Phillygenin, a Plant-Derived Lignan, Attenuates Renal Inflammation, Fibrosis, and Pyroptosis in a Unilateral Ureteral Obstruction Model. Nutrients. 2026;18(9):1421. doi:10.3390/nu18091421

BibTeX
@article{Chen2026,
  author = {Chen, Yu-Syuan and Yang, Shun-Fa and Kuo, Huey-Liang and Chuang, Haw-Ling and Chen, Chang-Mu and Lin, Ssu-Chia and Weng, Pei-Yu and Huang, Chun-Fa and Guan, Siao-Syun and Liu, Shing-Hwa and Wu, Cheng-Tien},
  title = {Phillygenin, a Plant-Derived Lignan, Attenuates Renal Inflammation, Fibrosis, and Pyroptosis in a Unilateral Ureteral Obstruction Model},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {9},
  pages = {1421},
  doi = {10.3390/nu18091421}
}
Kostenlos starten →